| Code | 90099 | ||||||||||
| MA number | 16/0118/81-CS | ||||||||||
| Product Form: | plv iol 1x600 IU+1x10 ml solv. (liek.skl.+liek.skl.) | ||||||||||
| MA Status: | D - Marketing Authorisation valid for an unlimited period | ||||||||||
| Type of procedure: | National | ||||||||||
| MAH, country: | Baxalta Innovations GmbH, Austria | ||||||||||
| Therapeutic Class: | 16 - ANTICOAGULANTIA (FIBRINOLYTICA, ANTIFIBRINOL.) | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 36 | ||||||||||
| Container: | glass container | ||||||||||
| Route of admin.: | Intravenous use |
| Prescription Status: | Medicinal product subject to medical prescription. |
| Legal basis: | Article 8(3) application - new active substance |
| MA issued: | 30.03.1981 |
| Dokument: |
DHPC Factor VII 9 11 2015 Baxter.pdf
|
| SPC: |
SPC_FACTOR VII NF Baxalta_10.2024.pdf
|
| PIL: |
PIL_FACTOR VII NF Baxalta_10.2024.pdf
|
| Safety feature | Yes |
| Data update: | 20.02.2018 |
